Abstract:A series of new coumarin-dithiocarbamate hybrids were designed, synthesized and evaluated as multifunctional agents for the treatment of Alzheimer's Disease (AD). The biological assays indicated that most of them showed potent inhibition and excellent selectivity towards acetylcholinesterase (AChE), and could inhibit self-induced β-amyloid (Aβ) aggregation. Especially, compound 4n presented the highest ability to inhibit AChE (IC50, 0.027 μM for hAChE) and good inhibition of Aβ aggregation (40.19% at 25 μM). Kinetic and molecular modeling studies revealed that 4n was a mixed-type inhibitor, which could interact simultaneously with the catalytic active site (CAS) and peripheral anionic site (PAS) of AChE. In addition, it also possessed specific metal-chelating ability, good BBB permeability and low toxicity on SH-SY5Y neuroblastoma cells. Moreover, compound 4n did not exhibit any acute toxicity in mice at doses up to 1000 mg/kg, and could reverse the cognitive dysfunction of scopolamine-induced AD mice. As far as we know, 4n was the first reported dithiocarbamate derivative with multifunctional activity. Its excellent profiles in vitro and effectivity in vivo highlight this structurally distinct compound as a potential lead compound in the research of innovative multifunctional drugs for AD.

Design, Synthesis and Evaluation of Novel Tacrine Coumarin Hybrids As Multifunctional Cholinesterase Inhibitors Against Alzheimer'S Disease

Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.

Design, Synthesis and Evaluation of Novel Tacrine-Rhein Hybrids As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids As Multifunctional Drug Candidates Against Alzheimer’s Disease

Multi-target Tacrine-Coumarin Hybrids: Cholinesterase and Monoamine Oxidase B Inhibition Properties Against Alzheimer's Disease.

Design, Synthesis and Evaluation of Novel Tacrine-Multialkoxybenzene Hybrids As Dual Inhibitors for Cholinesterases and Amyloid Beta Aggregation

Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.

Synthesis, Pharmacology and Molecular Docking on Multifunctional Tacrine-Ferulic Acid Hybrids As Cholinesterase Inhibitors Against Alzheimer's Disease

Syntheses of Coumarin–tacrine Hybrids As Dual-Site Acetylcholinesterase Inhibitors and Their Activity Against Butylcholinesterase, Aβ Aggregation, and Β-Secretase

Design, Synthesis and Biological Evaluation of Multifunctional Tacrine-Curcumin Hybrids As New Cholinesterase Inhibitors with Metal Ions-Chelating and Neuroprotective Property

Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease

Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.

A Novel Series of Tacrine-Selegiline Hybrids with Cholinesterase and Monoamine Oxidase Inhibition Activities for the Treatment of Alzheimer'S Disease

Synthesis and Evaluation of Heterobivalent Tacrine Derivatives As Potential Multi-Functional Anti-Alzheimer Agents

Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.

Design, Synthesis and Evaluation of Rivastigmine and Curcumin Hybrids As Site-Activated Multitarget-Directed Ligands for Alzheimer's Disease Therapy.

Design, Synthesis and Biological Evaluation of New Coumarin-Dithiocarbamate Hybrids As Multifunctional Agents for the Treatment of Alzheimer's Disease

Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.

Tacrine-Flurbiprofen Hybrids As Multifunctional Drug Candidates for the Treatment of Alzheimer's Disease

Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties.

Inhibition of Cholinesterase Activity and Amyloid Aggregation by Berberine-Phenyl-benzoheterocyclic and Tacrine-Phenyl-benzoheterocyclic Hybrids.